Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1950 2
1951 1
1956 1
1961 1
1963 1
1964 3
1965 3
1966 2
1968 1
1970 1
1972 1
1973 1
1974 1
1975 1
1978 1
1979 2
1980 4
1981 1
1982 1
1985 1
1986 1
1987 1
1988 5
1989 5
1997 1
2005 1
2006 1
2012 2
2013 1
2014 1
2015 4
2016 3
2017 2
2018 1
2019 1
2020 3
2021 2
2022 3
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

65 results

Results by year

Filters applied: . Clear all
Page 1
A Phase 2 Trial of Peresolimab for Adults with Rheumatoid Arthritis.
Tuttle J, Drescher E, Simón-Campos JA, Emery P, Greenwald M, Kivitz A, Rha H, Yachi P, Kiley C, Nirula A. Tuttle J, et al. Among authors: drescher e. N Engl J Med. 2023 May 18;388(20):1853-1862. doi: 10.1056/NEJMoa2209856. N Engl J Med. 2023. PMID: 37195941 Free article. Clinical Trial.
Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study.
Dougados M, van der Heijde D, Chen YC, Greenwald M, Drescher E, Liu J, Beattie S, Witt S, de la Torre I, Gaich C, Rooney T, Schlichting D, de Bono S, Emery P. Dougados M, et al. Among authors: drescher e. Ann Rheum Dis. 2017 Jan;76(1):88-95. doi: 10.1136/annrheumdis-2016-210094. Epub 2016 Sep 29. Ann Rheum Dis. 2017. PMID: 27689735 Free PMC article. Clinical Trial.
Asymmetric exophthalmos.
DRESCHER EP, BENEDICT WL. DRESCHER EP, et al. Arch Ophthal. 1950 Jul;44(1):109-28. doi: 10.1001/archopht.1950.00910020112007. Arch Ophthal. 1950. PMID: 15426478 No abstract available.
Evaluation of response to 13-valent conjugated pneumococcal vaccination in patients with rheumatoid arthritis receiving upadacitinib: results from a phase 2 open-label extension study.
Winthrop K, Vargas JI, Drescher E, Garcia C, Friedman A, Hendrickson B, Li Y, Klaff J, Kivitz A. Winthrop K, et al. Among authors: drescher e. RMD Open. 2022 Mar;8(1):e002110. doi: 10.1136/rmdopen-2021-002110. RMD Open. 2022. PMID: 35246470 Free PMC article. Clinical Trial.
Safety and efficacy of elsubrutinib or upadacitinib alone or in combination (ABBV-599) in patients with rheumatoid arthritis and inadequate response or intolerance to biological therapies: a multicentre, double-blind, randomised, controlled, phase 2 trial.
Fleischmann R, Friedman A, Drescher E, Singhal A, Cortes-Maisonet G, Doan T, Lu W, Wang Z, Nader A, Housley W, Cohen S, Taylor PC, Blanco R. Fleischmann R, et al. Among authors: drescher e. Lancet Rheumatol. 2022 Jun;4(6):e395-e406. doi: 10.1016/S2665-9913(22)00092-3. Epub 2022 Apr 27. Lancet Rheumatol. 2022. PMID: 38293957
[Bone metastases?].
Frahm R, Drescher E. Frahm R, et al. Among authors: drescher e. Radiologe. 1988 Jun;28(6):295-7. Radiologe. 1988. PMID: 3399676 German. No abstract available.
A Comparative Study to Assess the Efficacy, Safety, and Immunogenicity of YLB113 and the Etanercept Reference Product for the Treatment of Patients with Rheumatoid Arthritis.
Yamanaka H, Kamatani N, Tanaka Y, Hibino T, Drescher E, Sánchez-Bursón J, Rettenbacher M, Bhatia G, Gadve S, Shah C, Bakhle D. Yamanaka H, et al. Among authors: drescher e. Rheumatol Ther. 2020 Mar;7(1):149-163. doi: 10.1007/s40744-019-00186-3. Epub 2019 Dec 12. Rheumatol Ther. 2020. PMID: 31833011 Free PMC article.
65 results